Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2026-02-28 @ 11:15 AM
Study NCT ID:
NCT02623920
Status:
WITHDRAWN
Last Update Posted:
2017-05-19
First Post:
2015-09-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Sponsor:
Organization: